Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| HSBC Holdings | 1.79% | $13.23M | £172.71B | 45.06% | 82 Outperform | |
| Barclays | 1.33% | $9.81M | £54.05B | 63.65% | 77 Outperform | |
| Novartis AG | 1.29% | $9.51M | CHF198.09B | 3.36% | 77 Outperform | |
| ING GROEP | 1.20% | $8.90M | €61.53B | 33.38% | 63 Neutral | |
| Murata Manufacturing Co | 1.12% | $8.30M | ¥5.57T | 25.70% | 75 Outperform | |
| Standard Chartered | 1.09% | $8.08M | £32.54B | 77.21% | 75 Outperform | |
| ― | 1.09% | $8.06M | ― | ― | ― | |
| GlaxoSmithKline | 1.07% | $7.92M | £65.11B | 12.95% | 78 Outperform | |
| Roche Holding AG | 1.05% | $7.80M | CHF217.35B | 4.21% | 73 Outperform | |
| ArcelorMittal | 1.02% | $7.55M | €27.71B | 50.19% | 75 Outperform |